At Unicure, we produce a comprehensive range of specialty products targeting different therapeutic segments for treatment of patients, customised to each market we are present in. We clearly understand our customer's needs and use sophisticated and latest technology to present innovative solutions.
We identify complex areas that need innovation and commit ourselves to find a solution, within a defined time frame. We extend this thought-process to the markets we choose to enter and the capabilities we want to build. This business is spread in India along with other emerging countries across Africa, CIS, the Middle East and Central America .
India is at the heart of Unicure’s growth plans, with huge potential in the specialty segments. We have presence in high growth specialty segments of cardiology, antidiabetic, OTC and pain management where we have been able to provide consistently quality products for patient convenience and compliance. This has enabled us to take a lead in many sub therapeutic segments we are present in. We continue to thrive and build a robust product pipeline for our future growth.
Emerging markets are the major contributors in our business where we are present across Asia and CIS region . We chose each of the market where we are present in and designed a customised basket of products for each of these markets. We serve wide range of therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products. With the objective of building sustainable and scalable business model, we have been continuously filing products for registration in different countries of emerging markets, across therapeutic segments. This will ensure sustained growth for the company in years to come.